Nantahala Capital Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$91.8K Sell
6,703
-1,356,696
-100% -$18.6M ﹤0.01% 133
2025
Q1
$15.1M Sell
1,363,399
-8,239
-0.6% -$91.1K 0.6% 19
2024
Q4
$14.6M Buy
+1,371,638
New +$14.6M 0.63% 29